New MOVANTIK National Drug Code (NDC) Numbers
Pharmacists, Healthcare Providers, and Patients
Please note the following new MOVANTIK NDCs:
- MOVANTIK 12.5 mg: 82625-8801-1
- MOVANTIK 25 mg: 82625-8802-1
Effective September 1, 2023
Please review the entire policy to learn the types of End User information Valinor Pharma, LLC gathers, how Valinor Pharma, LLC uses that End User information, what End User information is disclosed and to what third parties, and how Valinor Pharma, LLC safeguards your End User information.
1. Information Valinor Pharma, LLC Collects
a) Personal Information and Non-Personal Information
“Personal Information” is information that identifies, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked to (directly or indirectly) an individual person or household. Personal Information includes, but is not limited to, your full name, email address, and any other information that could be used to personally identify you. We may ask you for Personal Information if, for example, you contact us through the Website.
We also collect non-Personal Information about you. Non-Personal Information includes, but is not limited to, your zip code (on its own) and individual preferences. Certain non-Personal Information would be considered a part of your Personal Information if it were combined with other identifiers (for example, combining your zip code with your street address) in a way that enables you to be identified. But the same pieces of information are considered non-Personal Information when they are taken alone or combined only with other non-Personal Information (for example, your gender only or your viewing preferences).
We use your Personal Information (in some cases, in conjunction with your non-Personal Information) mainly to respond to communications from you. We may also use your Personal Information to contact you with newsletters, marketing or promotional materials and other information that may be of interest to you. If you decide at any time that you no longer wish to receive such communications from us, please follow the unsubscribe instructions provided in any of the communications or update your account information.
We may also combine your Personal Information with non-Personal Information and aggregate it with information collected from other users to attempt to provide you with a better experience, to improve the quality and value of the Website, and to analyze and understand how the Website is used.
b) Usage Data
When you visit the Website, whether you are logged in or just browsing without logging in, our servers automatically record information that your browser sends whenever you visit a website. The information sent automatically by your browser is referred to as “Usage Data.” This Usage Data may include information such as the manufacturer and model of your device; your Internet Service Provider (ISP); your device’s Internet Protocol (“IP”) address (or other device identifier), browser type, and operating system; referring/exit pages; clickstream data; Website access times and dates, pages of the Website that you visit, the time spent on those pages, and information you search for on the Website; and other statistics.
We use this information for technical administration of the Website, including to monitor and analyze use of the Website, to increase the functionality and user-friendliness of the Website, and to better tailor the Website to End Users’ needs.
Usage Data may be Personal Information or non-Personal Information. Whenever we associate Usage Data with Personal Information, we will treat it as Personal Information.
2. Collection of Information
Valinor Pharma, LLC may use a number of different techniques and technologies to collect Personal Information, non-Personal Information, and Usage Data. For example, Valinor Pharma, LLC may use first-party cookies, Google Analytics services, log files, clear gifs, pixel tags, embedded scripts, and/or other technology to monitor the use of the Website.
We request certain information from you through the use of forms when you send us correspondence through the Website.
As is regular practice on many websites, the Website uses first-party cookies and other technologies to help us understand which parts of the Website are more popular and how much time users spend there. A cookie is a small amount of data that is sent to and stored on your device from our server. Cookies may, for example, allow a user to enter a password less frequently or remember a user’s preferences during an online session.
(c) Usage Data
Usage Data are collected automatically by the Website’s servers and software. For example, because the Website automatically collects Usage Data for all End Users that visit the Website, your Website session will be tracked. You agree that we may collect and use technical data and related information, including technical information about your device, system and application software, and peripherals, to maintain and support the Website generally.
Additionally, in some of our email messages, Valinor Pharma, LLC may use a “click-through URL” linked to content on the Website. When an End User clicks onto one of these URLs, the End User will pass through our server before arriving at the destination Web page. Valinor Pharma, LLC tracks this click-through data to help us determine End User interest in certain subject matter and measure the effectiveness of these End User communications. You can avoid being tracked in this way by not clicking text or graphic links in emails from Valinor Pharma, LLC.
Finally, we may use clear gifs or pixel tags, which are tiny graphic images, in order: (i) to advise us of what parts of the Website End Users have visited, (ii) to measure the effectiveness of any searches End Users perform, and (iii) to enable us to send emails in a format that End Users can read and tell us whether such emails have been opened in order to ensure us that we are sending messages that are of interest to End Users.
Some Web browsers may be configured to send Do Not Track signals to websites, or users may use similar mechanisms, to indicate a user’s preference that certain web technologies not be used to track the user’s online activity. The Website does not accept or process such Do Not Track signals or similar mechanisms.
3. Use and Sharing of Information by Valinor Pharma, LLC
The End User information that Valinor Pharma, LLC collects may be added to our databases and used for business purposes, including for marketing and promotional purposes, for a statistical analysis of End Users’ behavior, for product development, for content improvement, or to customize the content and layout of the Website. In addition, Valinor Pharma, LLC will, on occasion, send emails to you about the Website or third-party products. If you do not want to receive email from us, visit the “Opt Out” or “Unsubscribe” link at the bottom of any Valinor Pharma, LLC email to remove yourself from continued receipt of such email messages.
Valinor Pharma, LLC’s policy is not to share the End User information it collects with third parties other than as specified below, or where an End User expressly consents to our sharing of certain information with a third party. We may share End User information with third parties under the following circumstances:
(a) Business Partners and Vendors
We may use third-party service providers to perform certain business services, and we may disclose Personal Information to such service providers as needed for them to perform these business services. Service providers are only allowed to use, disclose, or retain the Personal Information to provide these services and are prohibited from selling Personal Information. Business services provided may include, but are not limited to, hosting services, communications services, website development services, payment processing services, fulfillment and shipping services, compliance services, quality control services, analytics services, survey and review services, call center and other communication services, and marketing services.
We may also disclose Personal Information to certain vendors for direct marketing purposes. Under certain circumstances, you may avoid having Valinor Pharma, LLC share your information with its business partners and vendors by not granting Valinor Pharma, LLC permission to share your information. Not granting Valinor Pharma, LLC permission to share your information with its business partners or vendors may limit your access to their services through the Website.
CALIFORNIA PRIVACY RIGHTS – Shine the Light Disclosures. If you reside in California, you may request certain general information regarding our disclosure of Personal Information during the preceding year to third parties for their direct marketing purposes. To make such a request, please contact us at email@example.com.
(b) Business Transfers
As we continue to develop our business, we may buy, sell, or share assets in connection with, for example, a merger, acquisition, reorganization, sale of assets, or bankruptcy. In such transactions, information about End Users generally is often a transferred business asset. In the event that Valinor Pharma, LLC itself or substantially all of Valinor Pharma, LLC’s assets are acquired, information about our End Users may be one of the transferred assets.
(c) Compliance with Law and Protection of Valinor Pharma, LLC and Others
4. International Transfer
By accessing and using the Website, you acknowledge and agree that Valinor Pharma, LLC controls and operates all parts of the Website from its offices in the United States of America and that the Website is intended for use by End Users located in the United States of America. Unless expressly stated to the contrary, Valinor Pharma, LLC makes no representation that the Website is appropriate or will be available for use in other locations.
5. Retention of Information and Changing or Deleting Your Information
We will retain the information (including Personal Information) as long as is reasonably necessary to fulfill the purpose for which it was collected, to comply with applicable laws and regulations, and/or to support any claim, defense, or declaration in a case or before a jurisdictional and/or administrative authority, arbitration, or mediation panel. Please contact us if you would like to review, update, correct or delete any Personal Information we may have about you. We may retain an archived copy of your records as required by law or for legitimate business purposes.
We use commercially reasonable security measures, such as encryption, to protect End User information. Please note that no security system is impenetrable. Accordingly, we do not guarantee the security of our databases, nor that information you supply won’t be intercepted while being transmitted to us over the Internet or other network. Any information you transmit to Valinor Pharma, LLC, you do at your own risk. We will make any legally required disclosures of any breach of the security, confidentiality, or integrity of your unencrypted electronically stored “personal data” (as defined in applicable state statutes on security breach notification) to you via email or conspicuous posting through the Website in the most expedient time possible and without unreasonable delay, as consistent with (i) the legitimate needs of law enforcement or (ii) any measures necessary to determine the scope of the breach and restore the reasonable integrity of the data system.
7. Children’s Privacy
The Website is intended for adult use only and is not directed towards children, minors, or anyone under the age of 18. If you are under the age of 13, you are not authorized to provide us with any Personal Information. If the parent or guardian of a child under 13 believes that the child has provided us with any Personal Information, the parent or guardian of that child should contact us at the email address below to have this Personal Information deleted from our files.
8. Contacting Us
Valinor Pharma, LLC
150 N. Riverside Plaza
Chicago, IL 60606
MOVANTIK® (naloxegol) is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
This site is intended for US health care professionals only.
Pharmacists, Healthcare Providers, and Patients
Please note the following new MOVANTIK NDCs: